Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
TDS Pharm CoXKRX:464280 40 Gross Margin % is 23.62% as of Jun. 2026, which is 7% below its 10-year median of 25.27. GuruFocus rates XKRX:464280 with a GF Score™ of 40/100. The stock has 1 warning sign investors should review. Among 942 Drug Manufacturers companies, TDS Pharm Co ranks worse than 82.59% on this metric.
The historical rank and industry rank for TDS Pharm Co's Gross Margin % or its related term are showing as below:
XKRX:464280'
s Gross Margin % Range Over the Past 10 Years
Min: 18.07 Med: 25.27 Max: 28.06
Current: 27.98
During the past 6 years, the highestGross Margin % of TDS Pharm Co was 28.06%. The lowest was 18.07%. And the median was 25.27%.
XKRX:464280's Gross Margin % is ranked worse than 82.59% of 942
companies
in the Drug Manufacturers industry
Industry Median: 48.23
vs XKRX:464280: 27.98
TDS Pharm Co had a gross margin of 23.62% for the quarter that ended in Jun. 2026 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for TDS Pharm Co was 9.40% per year.
TDS Pharm Co (XKRX:464280) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
TDS Pharm Co had a gross margin of 23.62% for the quarter that ended in Jun. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
TDS Pharm Co Gross Margin % Related Terms
TDS Pharm Co Gross Margin % Historical Data
* Premium members only.
The historical data trend for TDS Pharm Co's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XKRX:464280 vs LLY, JNJ, ABBV: Gross Margin % Comparison
For the Drug Manufacturers - General subindustry, TDS Pharm Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TDS Pharm Co Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, TDS Pharm Co's Gross Margin % distribution charts can be found below:
* The bar in red indicates where TDS Pharm Co's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
TDS Pharm Co (XKRX:464280) has a Gross Margin % of 23.62% as of Jun. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on TDS Pharm Co and its competitors. This is near median its historical median of 25.27. Over the past decade, TDS Pharm Co's Gross Margin % has ranged from 18.07 to 28.06. According to the industry distribution chart, TDS Pharm Co ranks #778 out of 942 companies in the Drug Manufacturers industry, placing it in the top 82.6%.
Is TDS Pharm Co's Gross Margin % too high?
TDS Pharm Co's current Gross Margin % of 23.62% is near median its 10-year median of 25.27. Over the past 10 years, this metric has ranged from a low of 18.07 to a high of 28.06. The Drug Manufacturers industry median Gross Margin % is 48.23. TDS Pharm Co's value of 23.62% is 51% below this industry median. Based on the distribution chart, TDS Pharm Co ranks #778 out of 942 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, TDS Pharm Co has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does TDS Pharm Co's Gross Margin % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, TDS Pharm Co ranks #778 out of 942 companies for Gross Margin %. This places TDS Pharm Co in the lower half of its industry. The industry median Gross Margin % is 48.23. TDS Pharm Co's value of 23.62% is 51% below this benchmark. Historically, TDS Pharm Co's own Gross Margin % has ranged from 18.07 to 28.06 over the past decade. While the company's 10-year median is 25.27 vs. the industry median of 48.23, TDS Pharm Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.23, based on 942 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TDS Pharm Co's current Gross Margin % of 23.62% is 51% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on TDS Pharm Co and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TDS Pharm Co's current Gross Margin % is 23.62%, which is near median its own 10-year median of 25.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TDS Pharm Co stock overvalued right now?
TDS Pharm Co (XKRX:464280) has a current Gross Margin % of 23.62%. The current Gross Margin % is 23.62%, which is near median its 10-year median of 25.27 and 51% below the Drug Manufacturers industry median of 48.23. TDS Pharm Co's overall GF Score™ is 40/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For TDS Pharm Co (XKRX:464280), the current Gross Margin % is 23.62% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
TDS Pharm Co Ltd is engaged in the development and manufacturing of the Transdermal Drug Delivery System (TDDS), which is growing as a high-growth business sector in the field of drug delivery systems (DDS). The Transdermal Drug Delivery System (TDDS) is a drug delivery system that delivers drugs through the skin at a controlled speed. It has the advantages of increasing patient compliance with drugs, maximizing efficacy and effectiveness, such as minimizing side effects in the liver and digestive organs, controlling absorption rate, controlling discontinuation, controlling effective blood concentration, and enabling long-term continuous administration, and reducing burden compared to oral and injection drugs.
40GF Score
Get the complete analysis for XKRX:464280
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:464280 has been successfully added to your 
